Bone marrow suppression

[1] Bone marrow suppression is a serious side effect of chemotherapy and certain drugs affecting the immune system such as azathioprine.This condition can rapidly lead to life-threatening infection, as the body cannot produce leukocytes in response to invading bacteria and viruses, as well as leading to anaemia due to a lack of red blood cells and spontaneous severe bleeding due to deficiency of platelets.Parvovirus B19 inhibits erythropoiesis by lytically infecting RBC precursors in the bone marrow and is associated with a number of different diseases ranging from benign to severe.[6] Bone marrow suppression due to azathioprine can be treated by changing to another medication such as mycophenolate mofetil (for organ transplants) or other disease-modifying drugs in rheumatoid arthritis or Crohn's disease.[10] Trilaciclib (COSELA), a CDK4/6 inhibitor, is administered before chemotherapy in small cell lung cancer to control chemotherapy-induced myelosuppression.
SpecialtyOncologyleukocyteserythrocytesthrombocytesBone marrowside effectchemotherapyimmune systemazathioprineleukemianon-small-cell lung cancerenhancerNonsteroidal anti-inflammatory drugsinfectionbacteriavirusesanaemiared blood cellsplateletsParvovirus B19erythropoiesisimmunocompromisedanemiamycophenolate mofetilrheumatoid arthritisCrohn's diseaseantibioticsNeutropeniaGM-CSFTrilaciclib (COSELA)CDK4/6 inhibitorsmall cell lung cancerHematopoietic stem cell transplantationWayback Machine